NET PROFIT (x1000 SEK)
EMPLOYEES
Eurofins Biopharma Product Testing Denmark A/S
Closing information (x1000 SEK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
20,397
|
16,876
|
13,006 |
| Total assets |
67,817
|
60,552
|
41,612 |
| Current assets |
55,095
|
50,537
|
31,794 |
| Current liabilities |
29,548
|
30,437
|
26,750 |
| Equity capital |
25,510
|
17,532
|
14,299 |
| - share capital |
963
|
944
|
978 |
| Employees (average) |
75
|
75
|
75 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
37.6%
|
29.0%
|
34.4% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
186.5%
|
166.0%
|
118.9% |
| Return on equity (ROE) |
80.0%
|
96.3%
|
91.0% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.